Related Experiment Video
Updated: Mar 29, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Pan-Immune-Inflammation Value as a Novel Predictor of Contrast-Associated Acute Kidney Injury in Patients Treated
Gökhan Çiçek1, Sadık Kadri Açıkgöz1, Eser Açıkgöz2
1Department of Cardiology, Ankara Bilkent City Hospital, University of Health Sciences, 06800 Ankara, Türkiye.
Insights
The Pan-Immune-Inflammation Value (PIV) can predict contrast-associated acute kidney injury (CA-AKI) in ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). Elevated PIV levels indicate a higher risk of developing CA-AKI after urgent PCI.
Area of Science:
- Cardiology
- Nephrology
- Biomarkers
Background:
- Contrast-associated acute kidney injury (CA-AKI) is a significant complication following procedures requiring intravascular contrast agents.
- Early identification of patients at high risk for CA-AKI is crucial, particularly for ST-segment elevation myocardial infarction (STEMI) patients undergoing urgent percutaneous coronary intervention (PCI).
Purpose of the Study:
- To evaluate the prognostic value of the Pan-Immune-Inflammation Value (PIV) in predicting CA-AKI.
- To assess PIV as a biomarker in STEMI patients undergoing urgent PCI.
Main Methods:
- Retrospective study of 2325 STEMI patients who underwent urgent PCI within 12 hours of symptom onset.
- CA-AKI defined as a >25% or ≥0.5 mg/dL increase in serum creatinine within 48-72 hours post-procedure.
- Analysis of admission PIV levels and their correlation with CA-AKI development using ROC and multivariate logistic regression.
Main Results:
- Patients who developed CA-AKI had significantly higher PIV levels (502.5 ± 324.5 vs. 264.7 ± 165.8; p < 0.001).
- A PIV cutoff value >320 demonstrated an AUC of 0.753 (95% CI: 0.740-0.787; p < 0.001), with 67% sensitivity and 66.9% specificity.
- Elevated PIV (>320) was an independent predictor of CA-AKI (OR 2.118; 95% CI: 1.329-3.790; p < 0.001), along with age, Killip class, and contrast volume.
Conclusions:
- Elevated admission PIV is a practical and independent biomarker for predicting CA-AKI in STEMI patients undergoing PCI.
- PIV offers a valuable tool for risk stratification and potential early intervention in this high-risk patient population.
Abstract:
Background/Objectives: Contrast-associated acute kidney injury (CA-AKI) remains an important cause of morbidity and mortality in patients undergoing procedures that require intravascular contrast administration. Therefore, the early identification of high-risk individuals is paramount, above all for ST-segment elevation myocardial infarction (STEMI) patients in need of urgent percutaneous coronary intervention (PCI). Methods: This retrospective study evaluated the prognostic value of the Pan-Immune-Inflammation Value (PIV), a composite inflammatory index, in predicting CA-AKI among patients presenting with STEMI who received urgent PCI within a 12 h window from the onset of symptoms. Results: This study recruited 2325 patient. CA-AKI was defined as a >25% or ≥0.5 mg/dL increase in serum creatinine within 48-72 h after the procedure. Patients were categorized into CA-AKI (+) and CA-AKI (-) groups. PIV levels were significantly higher in patients who developed CA-AKI (502.5 ± 324.5 vs. 264.7 ± 165.8; p < 0.001). ROC analysis identified a PIV cutoff value of >320, yielding an AUC of 0.753 (95% CI: 0.740-0.787; p < 0.001), with 67% sensitivity and 66.9% specificity. Multivariate logistic regression confirmed that PIV > 320 independently predicted CA-AKI (OR 2.118; 95% CI: 1.329-3.790; p < 0.001). In multivariable analysis, age, Killip class, contrast volume, and PIV > 320 were identified as independent predictors of CA-AKI. Conclusions: Elevated admission PIV serves as an independent and practical biomarker for predicting CA-AKI in STEMI patients undergoing PCI.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction

